Massachusetts Financial Services’s Impax Laboratories, Inc. IPXL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-14,414
Closed -$182K 899
2017
Q1
$182K Buy
14,414
+171
+1% +$2.06K ﹤0.01% 835
2016
Q4
$189K Buy
+14,243
New +$243K ﹤0.01% 844
2016
Q2
Sell
-508,650
Closed -$16.3M 893
2016
Q1
$16.3M Buy
508,650
+34,620
+7% +$1.22M 0.01% 517
2015
Q4
$20.3M Buy
474,030
+24,745
+6% +$988K 0.01% 496
2015
Q3
$15.8M Buy
449,285
+21,202
+5% +$955K 0.01% 534
2015
Q2
$19.7M Buy
428,083
+18,702
+5% +$888K 0.01% 522
2015
Q1
$19.2M Sell
409,381
-100,326
-20% -$3.99M 0.01% 538
2014
Q4
$16.1M Sell
509,707
-96,893
-16% -$2.84M 0.01% 561
2014
Q3
$14.4M Buy
606,600
+45,237
+8% +$1.16M 0.01% 596
2014
Q2
$16.8M Buy
561,363
+215,983
+63% +$5.83M 0.01% 563
2014
Q1
$9.12M Buy
345,380
+334,840
+3,177% +$8.37M 0.01% 594
2013
Q4
$265K Buy
+10,540
New +$235K ﹤0.01% 816

Other funds holding IPXL

Massachusetts Financial Services's IPXL Position: Q2 2017 in Review

Massachusetts Financial Services sold out of Impax Laboratories, Inc. (IPXL) in Q2 2017, closing a stake of 14,414 shares — an estimated $182K sold.

Massachusetts Financial Services first reported a position in IPXL in Q4 2013 and held it in 12 quarters. The position peaked at $20.3M in Q4 2015. 172 funds tracked by Wall St. Rank hold IPXL as of Q2 2017.

  • Massachusetts Financial Services reported no remaining Impax Laboratories, Inc. position as of Q2 2017 after selling out during the quarter.
  • Massachusetts Financial Services sold 14,414 Impax Laboratories, Inc. shares in Q2 2017, an estimated $182K.
  • Massachusetts Financial Services first reported a position in Impax Laboratories, Inc. in Q4 2013 and held it in 12 quarters.
  • Massachusetts Financial Services's Impax Laboratories, Inc. position peaked at $20.3M in Q4 2015.
  • 172 funds tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q2 2017.

Based on Massachusetts Financial Services's 13F filing for Q2 2017, filed 14 Aug 2017.